[骨肉瘤患者辅助化疗的生存情况及预后]
[Survival and prognosis in adjuvant chemotherapy for osteogenic sarcoma patients].
作者信息
Trapeznikov N N, Erëmina L A, Kutateladze T O, Siniukov P A, Amiraslanov A T
出版信息
Vopr Onkol. 1984;30(7):33-40.
The effect of adjuvant chemotherapy on survival and prognosis in osteogenic sarcoma versus basic clinico-roentgenomorphological characteristics of tumor was studied in 108 cases. Prognosis was found to depend on patient's age, site and size of tumor, but mainly on the roentgeno-morphological pattern of the latter. Osteolytic form appeared to have a better course in cases of adjuvant chemotherapy. This was matched by osteoplastic form requiring surgical treatment only. The results suggest a strictly differentiated approach to selection of treatment modality, particularly in cases of post-operative chemotherapy.
对108例骨肉瘤患者，研究了辅助化疗对其生存及预后的影响，并与肿瘤的基本临床-放射形态学特征进行对比。结果发现，预后取决于患者年龄、肿瘤部位及大小，但主要取决于肿瘤的放射形态学类型。在辅助化疗的情况下，溶骨型的病程似乎较好。这与仅需手术治疗的成骨型情况相符。结果提示，在选择治疗方式时应采取严格的差异化方法，尤其是在术后化疗的情况下。
Zotero 插件